Angela M. Silverman, CRNP

Provider is directly employed by MedStar Health

Publications

1. Soha Ahmad, MDa, Zhenyi Xue, MS, Angela Silverman, MSN. Joseph Lindsay, MD.  Complexity of the relation between Hemoglobin A1C, diabetes mellitus, and progression of coronary narrowing in postmenopausal women. Am J of Cardiology. 2013 Mar 15;111(6):793-9. doi: 10.1016/j.amjcard.2012.11.057. Epub 2013 Jan 5.


2. Mete M, Wilson C, Lee E, Silverman A, Fleg JL, Russell M, Stylianou M, Umans JG,  Wang W, Howard WJ, Howard BV, Ratner RE. Relationship of Glycemic Control to Lipid and Blood Pressure Lowering and Atherosclerosis: the SANDS Experience. J Diabetes Complications. 2011 July 18: doi:  10.1016/j.jdiacomp.2011.04. 


3. Wilson C, Huang CC, Shara N, Ennis J, Howard BV, Huentelman H, Lee ET Mete M, Russell M, Galloway JM, Silverman A, Stylianou M, Umans J, Weir MR, Yeh F, Ratner RE.  Within Trial Cost Effectiveness of Lower Targets for Blood Pressure and LDL Cholesterol in Diabetes:  The Stop Atherosclerosis in Native Diabetics Study. J Clin Lipidol. 2010 May;4 (3):165-172. 


4. Chami H, Baldwin C, Silverman A,  Zhang Y, Rapoport D, Punjabi N, Gottlieb D. Sleepiness, Quality of Life, and Sleep Maintenance in REM versus non-REM Sleep-disordered Breathing: J Respir Crit Care Med 2010 (181): 997–1002. 


5. Weir MR, Yeh F, Silverman A, Devereux RB, Galloway JM, Henderson JA, Howard WJ, Russell M, Wilson C, Ratner R, Sorkin J, Umans JG, Fleg JL, Stylianou M, Lee E, Howard BV. Safety and feasibility of achieving lower systolic blood pressure goals in persons with type 2 diabetes: the SANDS trial.  Journal Clinical Hypertension (Greenwich). 2009 Oct; 11(10):540-8. 


6. Howard WJ, Russell M, Fleg JL, Mete M, Ali T, Devereux RB, Galloway JM, Otvos JD, Ratner RE, Roman MJ, Silverman A, Umans JG, Weissman NJ, Wilson C, Howard BV.  Prevention of atherosclerosis with low-density lipoprotein cholesterol lowering – lipoprotein changes and interactions:  the SANDS study.  Journal of Clinical Lipidology, accepted  September 8, 2009.  Vol. 3, Issue 5, Pages 322-331, DOI: 10.1016


7. Silverman A, Huang CCJ, Russell M, Mete M, Roman MJ, Stylianou M, Lee ET, Yeh F, Fleg J, Wilson C, Henderson JA, Weir MR, Ratner RE, Howard BV.  Stop Atherosclerosis in Native Diabetics Study (SANDS):  Baseline Characteristics of the Randomized Cohort. Journal Health Disparities Research and Practice, Volume 3, Number 1, Spring 2009 pp. 29–42.


8. Howard BV, Comuzzie A, Ebbesson SO, Fabsitz RR, Howards WJ, Silverman A, Umans JF, Wang H, Weissman NJ.  Cardiovascular Disease Prevalence and its Relation to Risk factors in Alaska Eskimos. Nutrition, Metabolism and Cardiovascular Diseases (NMCD) April, 2009


9. Fleg JL, Mete M, Howard BV, Umans JG, Roman MJ, Ratner RE, Silverman A, Galloway JM, Henderson JA, Weir MR, Wilson C, Stylianou M, Howard WJ.  Effect of statins alone versus statins plus ezetimibe on carotid atherosclerosis in type 2 diabetes: the SANDS (Stop Atherosclerosis in Native Diabetics Study) trial. J Am Coll Cardiol. 2008 Dec 16;52(25):2198-205   PMID: 19095139  


10. Howard BV, Best L, Comuzzie A, Ebbesson OE, Epstein SE, Fabsitz RR, Howard Wm J, Silverman A, Wang H, Zhu J, Umans J.  C-Reactive Protein, Insulin Resistance, and metabolic Syndrome in a Population With a High Burden of Subclinical infection:  Insights from the Genetics of Coronary Artery Disease in Alaska Natives (GOCADAN Study).  Diabetes Care. 2008 Dec;31 (12): 2312-4. Epub 2008 September 16.  PMID: 18796618


11. Howard BV, Roman MJ, Devereux RB, Fleg JL, Galloway JM, Henderson JA, Howard WJ, Lee ET, Mete M, Poolaw B, Ratner RE, Russell M, Silverman A, Stylianou M, Umans JG, Wang W, Weir MR, Weissman NJ, Wilson C, Yeh F, and Zhu J.  Effect of Lower Targets for Blood Pressure and LDL Cholesterol on Atherosclerosis in Diabetes: The SANDS Randomized Trial JAMA. 2008 Apr 9;299(14):1678-89.  PMID: 18398080

1. Russell M, Fleg JL, Galloway J, Henderson JA, Howard WJ, Lee ET, Poolaw B, Ratner RE, Roman MJ, Silverman A, Stylianou M, Weir MR, Wilson C, Yeh F, Zhu J, Howard BV.  Examination of lower targets for low-density lipoprotein cholesterol and blood pressure in diabetes--the Stop Atherosclerosis in Native Diabetics Study (SANDS). Am Heart J. 2006; Nov;152(5):867-875. PMID: 17070147


2. Silverman A, Tripputi, M, Ouyang P, Tardif JC, Howard BV.   Effects of postmenopausal hormone therapy (PHT) on cardiovascular risk factors and coronary atherosclerosis in African American women. Circulation 112:II-815, 2005.


3. Howard BV, Hsia J, Ouyang P, Van Voorhees L, Lindsay J, Silverman A, Alderman EL, Tripputi M, Waters DD.  Postmenopausal Hormone Therapy Is Associated with Atherosclerosis Progression in Women With Abnormal Glucose Tolerance. Circulation 110:201-206, 2004. PMID: 15226212


4. Silverman, A, Drew, L, Harding, T, Strait, M, Siwy, M, Sevigny, E. Recruitment and Retention Issues with Women in an Angiographic Trial Using Controversial Agents. The Monitor 18:23-27, 2004.


5. Packer, M, Gheorghiade, M., Young, J., Costantini, P., Adams, K., Cody, R., Smith, L., Van Voorhees, L., Gourley, L., and Jolly, M., for the RADIANCE Study.  "Withdrawal of Digoxin from patients with Chronic Heart Failure Treated with Angiotensin-Converting-Enzyme Inhibitors".  NEJM 329:1, 1993


6. Milner MR, Semmes L, Silverman A, Shmookler BM: Familial Cushing's Syndrome ("Carney's Complex").  NEJM 322:1469-70, 1990.


7. The Multicenter Diltiazem Post Infarction Trial Research Group: The effect of diltiazem on mortality and reinfarction after myocardial infarction.  NEJM 319(7):385-92, 1988.


8. Lindsay J, Silverman A, Van Voorhees LB, Nolan N, Johnson D: Prognostic left ventricular function during exercise in asymptomatic patients with aortic regurgitation.  Angiology, 38 (5): 386-92, 1987.


9. Silverman, AT: Cardiac amyloidosis.  Heart and Lung, l6:60, l987.

ABSTRACTS

1. Silverman A, Mete M, Fleg J, Russell M, Ratner R, Roman M, Stylianou M, Umans J, Weir M, Howard B. Relationships Between Aggressive Systolic BP Goals, Nocturnal BP Dipping, and Carotid Atherosclerosis in Type 2 Diabetes: The SANDS Study. Accepted for poster presentation at the American Society of Hypertension Twenty−Sixth Annual Scientific Meeting and Exposition, May 21 2011.


2. Silverman, A, Carter, E. Improved Blood Pressure Control Among Low-Income African-American Barbershop and Hair Salon Clients: The Hair, Heart, and Health Program of Washington, DC. Circulation 122: A16921, 2010. 


3. Howard BV, Comuzzie A, Devereux RB, Ebbesson SO, Fabsitz RR, Howard WJ, Laston S, MacCluer JW, Silverman A, Wang H, Weissman NJ, Wenger CR (2009) CVD and Its Relation to Risk Factors in Alaska Eskimos: The GOCADAN Study
   
   Presented at the 49th Cardiovascular Disease Epidemiology and Prevention Conference, March 2009.

4. Silverman A, Hudnall T, Lee JR, Hair, Heart and Health Community Initiative. Presented at the 3rd National Leadership Summit on Eliminating Racial and Ethnic Disparities in Health, February 25-27, 2009, National Harbor, Maryland.

1. Ebbesson SO, Devereux RB, Fabsitz RR, Harris WS, Wang H, Roman MJ, Silverman A, Umans J, Howard BV (2008) Red Blood Cell Omega-3 Fatty Acids are Not Associated with Reduced Carotid Atheroslcerosis:  The Genetics of Coronary Artery Disease in Alaska Natives Study
   
   Presented at the 48th Cardiovascular Disease Epidemiology and Prevention Conference, March 2008.


2. M Russell, BV. Howard, A Silverman, RE. Ratner, F Yeh, J L. Fleg, J Galloway, W J. Howard, Safety and Efficacy of Achieving Lower LDL- and non-HDL-Cholesterol Goals in Type 2 Diabetes. Diabetes 57(Suppl 1); A158, 2008.


3. Howard BV, Best L, Comuzzie A, Ebbesson SOE, Epstein SE, Fabsitz RR, Howard WJ, Silverman A, Wang H, Zhu J and Umans J.  C-Reactive Protein, Insulin Resistance, and Metabolic Syndrome in a population with a High Burden of Subclinical Infection:  Insights from the GOCADAN Study. Diabetes Care published online on September 16, 2008, as dc08-0815.

8. Silverman A, Ratner RE, Lee E, Min N, Fleg J, Roman M, Howard BV.  Cardiovascular Disease (CVD) Risk Factors in Patients with Diabetes in the Stop Atherosclerosis in Native Diabetics Study (SANDS).  Presented at the 66th Session of the American Diabetes Association, Washington, DC, June 2006.  Diabetes 55(Suppl 1): pp.A-489, 2006.

1. Silverman A, Wenger CR, Howard BV (2006) Ensuring Voluntary Consent in Multicultural Observational Studies and Clinical Trials.
   
   Presented at the Society of Research Administrators annual meeting, October 2006. 


2. Silverman A, Triputti M, Howard BV. “Effects of postmenopausal hormone therapy (PHT) on cardiovascular risk factors and coronary atherosclerosis in African American women”. Presented at Scientific Sessions 2005- American Heart Association, New Orleans, La. 


3. Zhu J, Silverman A, Rushton-Reid S, “A Comparison of Fingerstick Method for Measuring Serum Lipid Levels to a Standard Hospital Based Method”. Presented at American Association of Clinical Chemistry, July 2005.


4. Hsai J, Silverman A, Howard BV. “Postmenopausal Hormone Therapy is Associated with Worse Progression of Coronary Artery Disease in Women with Abnormal Glucose Tolerance”. Presented at Scientific Sessions 2003- American Heart Association, Dallas, Tx. .


5. Silverman A, Lindsay J. “Racial Differences in Brachial Artery Reactivity Among Patients with Angiographically – Proven Coronary Artery Disease”. American College of Physicians – American Society of Internal Medicine.